Moreover, GSEA analysis indicated that a variety of pathways (e.g., cell cycle, TGF-β signaling pathway, pathways in cancer, and so on) involving the development and progression of tumors were activated in the high-risk group. This evidence concerns the gene TGFB1 and cancer.